BMS Archive

Plant · Scientific monograph

Rosa canina

Dog Rose / Rosehip

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Rheumatology Research, Pain Signaling Research

Research overview

Historical use

Rose hip, seed and combined hip-and-seed preparations are described as traditional medicinal materials in the pharmacological review. Their different composition and preparation should be distinguished; traditional use is not proof of clinical benefit [3].

Modern research context

A particular rosehip seed-and-husk powder has been investigated for osteoarthritis pain, with small manufacturer-supported studies limiting confidence [1][2]. A meta-analysis of three trials (287 participants; median duration three months) found a small pain-score benefit, but all trials were supported by the same manufacturer and independent replication was requested [1]. A double-blind crossover study enrolled 94 patients with hip or knee osteoarthritis and compared seed-and-husk powder with placebo for three months per period [2]. Evidence is provisionally Level B for pain outcomes with that studied preparation, not all rosehip teas, oils, species mixtures or products. Other uses remain insufficiently established [3][4]. Full-text quality appraisal remains pending.

Adverse effects

Adverse-event frequencies, rare events and long-term safety are not established by the accessible abstracts. The meta-analysis specifically calls for further efficacy and safety evaluation [1]. Absence of a detailed adverse-event table in an abstract is not absence of adverse effects [1][2].

Contraindications

Known hypersensitivity to the product is a precautionary reason to avoid exposure. Other specific contraindications, pediatric safety and perioperative washout intervals could not be established from the selected sources; no validated interval is proposed [1][3].

Clinical and phytochemical data

Used part

The clinical evidence concerns powder made from the seeds and shells/husks of a Rosa canina subspecies. Seed oil, seed-free hip material, teas and multi-species rosehip blends are not interchangeable with this powder [2][3].

Primary active compounds

  • Lipophilic constituents investigated in rosehip/seed pharmacology; specific clinical standardization not established in the accessible abstracts [3]

Mechanism of action

The pharmacological review describes antioxidant and anti-inflammatory effects involving lipophilic constituents in experimental preparations. A clinically established receptor or enzyme target and proof that these mechanisms cause pain changes are lacking; mechanistic evidence must not be equated with disease modification [3].

Pharmacokinetics

Absorption

Human absorption parameters for the studied complete powder were not established in the selected sources [1][3].

Distribution

Human tissue distribution and protein binding for the studied powder were not established [3].

Metabolism

Human metabolite and clinically meaningful CYP interaction profiles for the studied powder were not established [3].

Excretion

Human clearance, half-life and renal/biliary recovery of the complete powder were not established [3].

Safety and interactions

Drug interactions

No clinically quantified herb–drug interaction or validated CYP interaction profile was established in the selected sources. This is an evidence gap rather than proof of no interaction; concurrent medication and product composition require individual assessment [1][3].

Toxicity

Long-term toxicity, rare hepatic or renal events and maximum tolerable exposure are unresolved. The three-trial pain meta-analysis does not establish broad safety of other rosehip preparations [1].

Special precautions

Pregnancy

Pregnancy safety for the studied medicinal powder could not be established from the selected sources; this is an evidence gap, not proof of fetal safety or harm [1][3].

Lactation

Milk transfer and infant safety for the studied medicinal powder could not be established from the selected sources; an evidence-based safety recommendation cannot be made here [1][3].

Hepatic impairment

No hepatic-impairment study or validated dose adjustment was identified in the selected sources [1][3].

Renal impairment

No renal-impairment study or validated dose adjustment was identified in the selected sources [1][3].

Sources and references

  1. [1] - Christensen R, Bartels EM, Altman RD, Astrup A, Bliddal H. Does the hip powder of Rosa canina (rosehip) reduce pain in osteoarthritis patients?--a meta-analysis of randomized controlled trials. Osteoarthritis and cartilage, 2008. PMID: 18407528. DOI: 10.1016/j.joca.2008.03.001
  2. [2] - Winther K, Apel K, Thamsborg G. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial. Scandinavian journal of rheumatology, 2005. PMID: 16195164. DOI: 10.1080/03009740510018624
  3. [3] - Chrubasik C, Roufogalis BD, Müller-Ladner U, Chrubasik S. A systematic review on the Rosa canina effect and efficacy profiles. Phytotherapy research : PTR, 2008. PMID: 18384191. DOI: 10.1002/ptr.2400
  4. [4] - Chrubasik C, Duke RK, Chrubasik S. The evidence for clinical efficacy of rose hip and seed: a systematic review. Phytotherapy research : PTR, 2006. PMID: 16395741. DOI: 10.1002/ptr.1729

Additional source links

Continue browsing